ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Impact of Low Free Testosterone on Prostate Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 235321" data-attributes="member: 13851"><p>[URL unfurl="true"]http://urology.uci.edu/dept_faculty_ahlering.shtml[/URL]</p><p></p><p><strong>Professional Biography</strong></p><p></p><p><em><strong>Dr. Thomas Ahlering is a highly regarded surgeon in Urologic cancers.</strong> He received his medical degree at St. Louis University School of Medicine, followed by a residency in urology at the University of Southern California in Los Angeles and a two-year fellowship in urologic oncology under the clinical training of Dr. Donald G. Skinner. Following his training, he was the Chief of the Division of Urologic Oncology at the City of Hope (1986-1992) when he was recruited as Chief of the Division of Urology at UC Irvine in 1992-2002. <strong>His years of experience in the treatment of prostate, bladder, kidney, and testicular cancers have placed him as one of original America's Best Doctors since his selection in 1994. He has received local, national, and international recognition for his expertise in urologic oncology, particularly in the development of Robotic radical prostatectomy with the da Vinci robot. He has performed more than 2500 such surgeries, including the first robotic prostatectomy surgeries in Southern California, Denmark, Australia, and Canada.</strong></em></p><p><em><strong></strong></em></p><p><em><strong>Since 2002, Dr. Ahlering’s research efforts have concentrated on maximizing functional recovery and patient-reported outcomes following robot-assisted radical prostatectomy. His work has been highly regarded among the scientific community, with over 400 published abstracts and journal articles. Dr. Ahlering has consistently been recognized as a top 1-2% expert in academic prostatectomy research, and most recently was recognized as a Top 2% of Medical Scientists in the World in a Stanford Study.</strong> Dr. Ahlering is highly awarded and acknowledged amongst his peers including the Lifetime Achievement Award in Robotic Surgery at North American Robotic Urology Symposium; the Outstanding Faculty Achievement - Lauds and Laurels Awards from the University of California Irvine Alumni Association and Mentor of the Year from the UCI Institute of Clinical and Translational Science.</em></p></blockquote><p></p>
[QUOTE="madman, post: 235321, member: 13851"] [URL unfurl="true"]http://urology.uci.edu/dept_faculty_ahlering.shtml[/URL] [B]Professional Biography[/B] [I][B]Dr. Thomas Ahlering is a highly regarded surgeon in Urologic cancers.[/B] He received his medical degree at St. Louis University School of Medicine, followed by a residency in urology at the University of Southern California in Los Angeles and a two-year fellowship in urologic oncology under the clinical training of Dr. Donald G. Skinner. Following his training, he was the Chief of the Division of Urologic Oncology at the City of Hope (1986-1992) when he was recruited as Chief of the Division of Urology at UC Irvine in 1992-2002. [B]His years of experience in the treatment of prostate, bladder, kidney, and testicular cancers have placed him as one of original America's Best Doctors since his selection in 1994. He has received local, national, and international recognition for his expertise in urologic oncology, particularly in the development of Robotic radical prostatectomy with the da Vinci robot. He has performed more than 2500 such surgeries, including the first robotic prostatectomy surgeries in Southern California, Denmark, Australia, and Canada. Since 2002, Dr. Ahlering’s research efforts have concentrated on maximizing functional recovery and patient-reported outcomes following robot-assisted radical prostatectomy. His work has been highly regarded among the scientific community, with over 400 published abstracts and journal articles. Dr. Ahlering has consistently been recognized as a top 1-2% expert in academic prostatectomy research, and most recently was recognized as a Top 2% of Medical Scientists in the World in a Stanford Study.[/B] Dr. Ahlering is highly awarded and acknowledged amongst his peers including the Lifetime Achievement Award in Robotic Surgery at North American Robotic Urology Symposium; the Outstanding Faculty Achievement - Lauds and Laurels Awards from the University of California Irvine Alumni Association and Mentor of the Year from the UCI Institute of Clinical and Translational Science.[/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Impact of Low Free Testosterone on Prostate Cancer
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top